Arizona Clinical Translational Research

Dr. Woods' career has spanned industry, clinical practice and academia focusing on human Phase II-III human clinical research, veterinary clinical studies, business development, technology licensing and regulatory affairs. Dr. Woods has led the development of various biomedical technologies with dual applications in human and veterinary medicine including antivenoms, tumor imaging agents, immuno-therapeutics, anti-infectives, and biological scaffolds. Notably, his work in comparative ophthalmology was the basis for the first human suprachoroidal glaucoma implant. His recent work includes biological weapons threat assessment for US Department of Defense, assimilation of exiled foreign scientists for the US Department of State, biosurveillance of highly pathogenic avian influenza (H5N1), and COVID-19 surveillance in healthcare workers. Craig received his BS (biology), MS (veterinary anatomy) and DVM from the University of Missouri and his MBA from Arizona State University. In addition to his role at the One Medicine Group, Dr. Woods serves as a consultant to the biopharma industry, is an adjunct faculty member at Arizona State University, and a volunteer board member for UCP of Central Arizona.

Dr. Brett Cordes graduated from Iowa State University in 1996, with a career spanning industry and clinical practice at the interface between animal and human healthcare. Dr. Cordes, also an entrepreneur and business developer, founded Arizona Animal Hospital in 2014. His practical and progressive approach to clinical medicine has resulted in Arizona Animal Hospital becoming one of the leading small animal practices in the country.

Dr. Cordes is widely recognized for his work in oncology safety and compounded pharmaceuticals, which has evolved into standards implemented across many healthcare industries worldwide today. Dr. Cordes currenly serves in a five-year role with US Pharmacopeia (USP) as an expert committee member, primarily steering USP Chapters <795>, <797> and <800>, and was appointed by Senator John McCain to the board of TGen’s National Advisory Council for Dog and Human Precision Medicine.

Dr. Fossum is a world-renowned board-certified veterinary surgeon, author of the best-selling textbook Small Animal Surgery (in its 5^th edition), and a serial entrepreneur. Her textbook has been translated into over a dozen languages. Dr Fossum’s background includes more than 35 years of educating veterinarians and pet-owners regarding diseases of companion animals. She has given over 1000 invited lectures to veterinarians throughout the world and has served as the keynote speaker at some of these meetings. She has been honored with numerous awards, including Distinguished Alumni and Continuing Educator of the Year.

Dr. Fossum is the CEO and Founder of Dr. Fossum’s Pet Care and CEO and President of Phoenix Animal Wellness. These companies are developing and commercializing safe, efficacious, and reliable wellness products for pets and livestock. She is also the CEO and Co-Founder of Veterinary Intelligent Solutions, which is developing AI solutions for veterinary medicine. Dr. Fossum has served as the principal investigator for over 30 million dollars in research funding from industry and the federal government. In 2018 she was the Special Assistant to the Secretary of Energy, developing STEM initiatives for the DOE. She is also the founder and former Director and Executive Director of the Texas A&M Institute for Preclinical Studies (TIPS), a 60-million-dollar venture at Texas A&M University which promotes public-private partnerships to speed the development of medical devices and drugs. In addition to her textbook which is considered to be the bible of veterinary surgery, Dr. Fossum has over 100 publications and numerous book chapters to her credit.

Dr. Sweazea is an Associate Professor with tenure in the College of Health Solutions at Arizona State University. Dr. Sweazea’s education and training are in the areas of comparative physiology, endocrine and cardiovascular physiology, and she has been an independent investigator for 17 years.

Dr. Sweazea currently focuses on utilizing a comparative physiology approach to uncover novel strategies and therapeutics to prevent or treat metabolic diseases including cardiovascular diseases and diabetes arising from poor nutrition. Her approach spans the translational research spectrum to include traditional animal models (rodents), negative models of disease (birds), educational approaches, in addition to clinical trials through which the translational potential of basic science discoveries are evaluated. Dr. Sweazea has presented an invited seminar on glucose regulation in vertebrates at the 2023 American Physiology Summit in Long Beach, CA as well as an invited seminar on the cardiovascular effects of a high fat diet in rodents at the American Oil Chemists Society conference in 2020. Her research accomplishments earned her the 2015 New Investigator Award from the Comparative and Evolutionary Physiology section of the American Physiological Society and she was elected Fellow of the American Heart Association Council on Basic Cardiovascular Sciences in 2019.

ABOUT us

CO-FOUNDERS

SCIENCE and RESEARCH ADVISORS

FACILITIES

Arizona Animal Hospital ranked #44 by USA Today''s list of America's Best Veterinary Hospitals.